Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 309 clinical trials
A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH)

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to

tumour necrosis
tumor necrosis factor
body mass index
antirheumatics
baricitinib
  • 872 views
  • 03 May, 2022
  • 107 locations
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement (PEPPER)

PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.

aspirin
anticoagulants
rivaroxaban
total knee replacement
pulmonary embolism
  • 340 views
  • 25 Feb, 2022
  • 20 locations
API-CAT STUDY for APIxaban Cancer Associated Thrombosis (API-CAT)

thromboembolism (VTE) in patients with active cancer who have completed at least 6 months of anticoagulant therapy for treating a documented index event of proximal deep venous thrombosis (DVT) (symptomatic or

  • 33 views
  • 07 Feb, 2022
  • 64 locations
Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

complications, but interruption during TAVI may increase the risk for thromboembolic events (i.e. stroke, systemic embolism, myocardial infarction). Recent observational data suggest that periprocedural

anticoagulants
myocardial infarction
infarct
stenosis
tavi
  • 8 views
  • 24 Mar, 2022
  • 1 location
Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI

indication for NOAC undergoing PCI in the setting of ACS. Thromboembolic events, stent thrombosis and death will be evaluated for estimation of events between both groups. Data will be pooled for this

  • 0 views
  • 08 May, 2021
  • 1 location
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG (PACES)

The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background

clopidogrel
vitamin k
coronary artery bypass graft
antiplatelet therapy
aspirin
  • 112 views
  • 27 Apr, 2022
  • 43 locations
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study (ONCO DVT)

The purpose of this study is to determine the optimal duration of anticoagulation therapy (3 months versus 12 months) with direct oral anticoagulant (edoxaban) for isolated distal deep vein thrombosis.

anticoagulants
deep venous thrombosis of lower extremity
deep vein thrombosis
thrombosis
edoxaban
  • 15 views
  • 09 Feb, 2022
  • 1 location
Screening for Cancer in Patients With Unprovoked VTE

the search for neoplasms in patients with unprovoked venous thromboembolic disease at high risk of developing cancer at follow-up. Introduction: Cancer screening in patients with unprovoked

thrombosis
deep venous thrombosis of lower extremity
clot
embolism
deep vein thrombosis
  • 0 views
  • 18 Dec, 2021
  • 9 locations
Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients (NOAC-GAP)

gastrointestinal bleeding (GIB) in patients with atrial fibrillation (AF) who require the prophylactic medication for stroke prevention. These patients are at increased risk for devastating future thromboembolic

  • 5 views
  • 03 Feb, 2022
  • 3 locations
Dabigatran for Mitral Stenosis Atrial Fibrillation

thromboembolism due to the formation and embolism of left atrial thrombi. Current international guidelines recommend non-vitamin K oral anticoagulants (NOACs) for stroke prevention amongst these patients with non

  • 0 views
  • 28 Jan, 2021
  • 1 location